Top Abstract Purchase Related
Home
>
Node
>
Subnode

The tocopherol acetate and splenin correction of the immunological disorders in patients with viral hepatitis B

Frolov, V.M.; Peresadin, N.A.; Dekaliuk, I.V.; Pshenichnyĭ, I.Ia.

Likars'ka Sprava 1992(4): 90-91

1992

ISSN/ISBN: 1019-5297
PMID: 1441392
Document Number: 391700
Inclusion of tocopherol acetate and splenin into complex treatment of viral hepatitis B (VHB) ensures a marked immunomodulating effect consisting in control of T-lymphopenia, normalization of helper-suppressor ratio, reduction of circulating immune complexes and a tendency to restoration of normal ratio between separate fractions of immune complexes, stimulation of phagocytic activity of monocytes of the peripheral blood. Splenin and tocopherol acetate are recommended in the complex treatment of hepatitis B.

Document emailed within 1 workday
Secure & encrypted payments

Il'nyts'kyĭ, R.I. 2014: Immunological Reactivity and Correction of Immunological Disorders by Biological Medicines in Patients with Chronic Obstructive Pulmonary Disease Exacerbations Likars'ka Sprava 2014(7-8): 22-27
Zemskov, A.M.; Samodaĭ, V.G. 2006: Immunological disorders and correction of them in surgical patients with atherosclerosis obliterance Khirurgiia 2006(6): 38-41
Leĭbenzon, A.S. 1995: Immunological markers in patients with a history of viral hepatitis B and D and HBsAg carriers Likars'ka Sprava 1995(3-4): 107-109
Zhurkin, A.T.; Dubinina, E.E.; Koriagin, V.N. 1989: Immunological indicators and superoxide dismutase activity in the erythrocytes of patients with viral hepatitis Terapevticheskii Arkhiv 61(2): 58-60
Miasoedova, E.E.; Nazarov, S.B. 2003: Use of alpha-tocopherol in correction of red blood (erythron) system disorders in rats with acute nitrite intoxication Eksperimental'naia i Klinicheskaia Farmakologiia 66(5): 35-39
Salaspuro, M.P.; Laitinen, O.I.; Lehtola, J.; Makkonen, H.; Räsänen, J.A.; Sipponen, P. 1976: Immunological parameters, viral antibodies, and biochemical and histological findings in relatives of patients with chronic active hepatitis and primary biliary cirrhosis Scandinavian Journal of Gastroenterology 11(3): 313-320
Nedoszytko, B.; Michalska, Z.; Dubicka, M.; Gajda, A. 1987: Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. II. Immunological evaluation Wiadomosci Lekarskie 40(21): 1469-1474
Bogachik, L.I.; Vasil'eva, N.A.; Donich, N.S. 1981: Correction of carbohydrate assimilation in viral hepatitis Vrachebnoe Delo 1981(4): 121-122
Grigor'ev, M.G.; Matusis, Z.E.; Pylaeva, S.I.; Pakhomov, S.P.; Bublik, L.N. 1984: Disorders of the immunological status and their possible correction in severe burns Gematologiia i Transfuziologiia 29(7): 13-16
Hess, G.; Meyer zum Büschenfelde, K.H. 1980: Immunological mechanisms in acute viral hepatitis Die Medizinische Welt 31(42): 1493-1498
Loginov, A.S.; Tsaregorodtseva, T.M.; Zotina, M.M.; Serova, T.I.; Iakimchuk, G.N. 1995: The immunological diagnosis of chronic viral hepatitis Terapevticheskii Arkhiv 67(11): 5-7
Lau, G.K.; Wang, B.; Carman, W. 1998: Immunological approaches to the breakdown of hepatitis B viral persistence Chinese Medical Journal 111(6): 560-564
Arutiunian, V.M.; Eganian, G.A.; Minasian, G.A.; Engibarian, A.A. 1983: Use of alpha-tocopherol acetate (vitamin E) and sodium nucleinate in the treatment of patients with stomach and duodenal ulcer Klinicheskaia Meditsina 61(4): 52-54
Singeisen, M.; Stalder, G.A.; Bianchi, L.; Gudat, F.; Schmid, M. 1977: Immunological aspects of acute viral hepatitis treated with corticosteroids Schweizerische Medizinische Wochenschrift 107(48): 1762-1764
Cherevashchenko, L.A.; Aĭvazov, V.N.; Iordanova, I.I. 2000: Clinico-immunological disorders in the late sequelae of craniocervical trauma and their correction at the health resort stage Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2000(2): 26-27
Gol'zand, I.V.; Volkov, V.O.; Goriacheva, L.G.; Shibova-Borskaia, L.M.; Romantsov, M.G. 1982: Clinico-immunological and epidemiological characteristics of acute viral hepatitis in children in the first 3 years of life Pediatriia 1982(10): 44-46
González-Michaca, L.; Mercado, A.; Gamba, G. 2000: Viral C hepatitis in patients with end stage renal disease. II. Viral genotypes Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 52(5): 491-496
Pimenov, L.T.; Churshin, A.D.; Ezhov, A.V. 1997: Piracetam and tocopherol acetate ability to potentiate clinical effect of antianginal drugs in presenile and senile patients with ischemic heart disease (unstable angina) Klinicheskaia Meditsina 75(1): 32-35
Makos', R.P.; Mateĭko, G.B. 1988: Cardiovascular disorders in adolescents with viral hepatitis Vrachebnoe Delo 4: 119-121
Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164